1 |
Xu H, Wang H. Immune cells in alcohol-related liver disease. Liver Research 2022. [DOI: 10.1016/j.livres.2022.01.001] [Reference Citation Analysis]
|
2 |
Hao X, Sun G, Zhang Y, Kong X, Rong D, Song J, Tang W, Wang X. Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges. Front Cell Dev Biol 2021;9:775462. [PMID: 34869376 DOI: 10.3389/fcell.2021.775462] [Reference Citation Analysis]
|
3 |
Cheng L, Hu S, Ma J, Shu Y, Chen Y, Zhang B, Qi Z, Wang Y, Zhang Y, Zhang Y, Cheng P. Long noncoding RNA RP11-241J12.3 targeting pyruvate carboxylase promotes hepatocellular carcinoma aggressiveness by disrupting pyruvate metabolism and the DNA mismatch repair system. Mol Biomed 2022;3:4. [PMID: 35122182 DOI: 10.1186/s43556-021-00065-w] [Reference Citation Analysis]
|
4 |
Hu J, Gao Q, Yang Y, Xia J, Zhang W, Chen Y, Zhou Z, Chang L, Hu Y, Zhou H, Liang L, Li X, Long Q, Wang K, Huang A, Tang N. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation. Theranostics 2021;11:805-23. [PMID: 33391506 DOI: 10.7150/thno.50230] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Zhang DD, Wang WE, Ma YS, Shi Y, Yin J, Liu JB, Yang XL, Xin R, Fu D, Zhang WJ. A miR-212-3p/SLC6A1 Regulatory Sub-Network for the Prognosis of Hepatocellular Carcinoma. Cancer Manag Res 2021;13:5063-75. [PMID: 34234551 DOI: 10.2147/CMAR.S308986] [Reference Citation Analysis]
|